Skip to main content

Advertisement

Log in

Impact of obesity on treatment-related adverse events, disease recurrence, and survival in women with cervical carcinoma

  • Original Research
  • Published:
Journal of Radiation Oncology

Abstract

Objectives

To review and report the influence of body mass index (BMI) on oncologic outcomes and toxicity in women treated with radiotherapy for locally advanced cervical cancer.

Methods

After obtaining institutional review board approval, we reviewed the records of patients with stage IB1 to IVB cervical cancer treated at our institution between 1983 and 2009. Eligible patients underwent definitive radiotherapy with external beam radiation therapy or chemoradiation and low dose rate (LDR) brachytherapy. Patient, tumor and treatment characteristics, treatment-induced adverse events (AEs), and treatment outcomes were reviewed and reported based on BMI category.

Results

This study identified 223 patients, consisting of stages I, II, III, and IV cervical cancer (36, 42, 16, and 6 %, respectively), and BMI categories <18.5, 18.5–24.9, 25–29.9, and >30 (8, 39, 22, and 31 %, respectively). Median follow-up was 30 months. Overweight and obese women (BMI > 25) were more likely to experience acute grade 3–4 skin AEs (p = 0.02). Underweight patients (BMI < 18.5) received higher bladder point radiation dose (p = 0.04) and had shorter distance between the bladder point and the point of maximum dose (p = 0.02). Women with BMI ≥30 had increased overall survival (OS) (multivariate hazard ratio [HR] 0.471, 95 % confidence interval [CI] 0.263–0.841, p = 0.01) and progression-free survival (PFS) (HR 0.513, 95 % CI 0.305–0.862, p = 0.01).

Conclusions

Treatment-related outcomes differed based on patient BMI. Future prospective studies are justified to identify whether interventions such as image-guided and adaptive treatment planning and intensity-modulated radiation therapy (IMRT) are effective in reducing treatment-related AEs for obese and underweight patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Flegal KM, Carroll MD, Kit BK et al (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307:491–497

    Article  PubMed  Google Scholar 

  2. Wang Y, Beydoun MA (2007) The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28

    Article  CAS  PubMed  Google Scholar 

  3. Schuster RJ, Tasosa J, Terwoord NA (2008) Translational research-implementation of NHLBI obesity guidelines in a primary care community setting: the physician obesity awareness project. J Nutr Health Aging 12:764S–769S

    CAS  PubMed  Google Scholar 

  4. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638

    Article  PubMed  Google Scholar 

  5. Calle EE, Thun MJ (2004) Obesity and cancer. Oncogene 23:6365–6378

    Article  CAS  PubMed  Google Scholar 

  6. Modesitt SC, van Nagell JR Jr (2005) The impact of obesity on the incidence and treatment of gynecologic cancers: a review. Obstet Gynecol Surv 60:683–692

    Article  PubMed  Google Scholar 

  7. Polednak AP (2008) Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. Cancer Detect Prev 32:190–199

    Article  PubMed  Google Scholar 

  8. Ligibel JA, Alfano CM, Courneya KS et al (2014) American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol 32(31):3568–3574

    Article  PubMed  Google Scholar 

  9. Ferrante JM, Chen PH, Crabtree BF et al (2007) Cancer screening in women: body mass index and adherence to physician recommendations. Am J Prev Med 32:525–531

    Article  PubMed  PubMed Central  Google Scholar 

  10. Garfinkel L (1985) Overweight and cancer. Ann Intern Med 103:1034–1036

    Article  CAS  PubMed  Google Scholar 

  11. Munstedt K, Wagner M, Kullmer U et al (2008) Influence of body mass index on prognosis in gynecological malignancies. Cancer Causes Control 19:909–916

    Article  PubMed  Google Scholar 

  12. Kizer NT, Thaker PH, Gao F et al (2011) The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy. Cancer 117:948–956

    Article  PubMed  PubMed Central  Google Scholar 

  13. Yoon WS, Yang DS, Lee JA (2012) Risk factors related to interfractional variation in whole pelvic irradiation for locally advanced pelvic malignancies. Strahlenther Onkol 188:395–403

    Article  CAS  PubMed  Google Scholar 

  14. Choi M, Fuller CD, Wang SJ (2009) Effect of body mass index on shifts in ultrasound-based image-guided intensity-modulated radiation therapy for abdominal malignancies. Radiother Oncol 91:114–119

    Article  PubMed  Google Scholar 

  15. Morrow NV, Lawton CA, Qi XS (2012) Impact of computed tomography image quality of image-guided radiation therapy based on soft tissue registration. Int J Radiat Oncol Biol Phys 82(5):e777–e738

    Article  Google Scholar 

  16. Kapp KS, Stuecklschweiger GF, Kapp DS et al (1997) Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy. Radiother Oncol 42:143–153

    Article  CAS  PubMed  Google Scholar 

  17. Eifel PJ, Jhingran A, Bodurka DC et al (2002) Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 20:3651–3657

    Article  PubMed  Google Scholar 

  18. Von Gruenigen VE, TC F et al (2006) Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study. Cancer 15:2786–2791

    Article  Google Scholar 

  19. Mayr NA, Taoka T, Yuh WT et al (2002) Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 52:14–22

    Article  PubMed  Google Scholar 

  20. Lin LL, Hertan L, Rengan R et al (2012) Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance. Int J Radiat Oncol Biol Phys 83:670–675

    Article  PubMed  Google Scholar 

  21. Uppot RN, Sahani DV, Hahn PF et al (2007) Impact of obesity on medical imaging and image-guided intervention. AJR Am J Roentgenol 188(2):433–440

    Article  PubMed  Google Scholar 

  22. Ahamad A, D’souza W, Salehpour M et al (2005) Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size. Int J Radiat Oncol Biol Phys 62(4):1117–1124

    Article  PubMed  Google Scholar 

  23. Waggoner SE, Darcy KM, Fuhrman B (2006) Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study. Gynecol Oncol 103:853–858

    Article  CAS  PubMed  Google Scholar 

  24. Polterauer S, Grimm C, Seebacher V et al (2010) The inflammation-based Glasgow Prognostic Score predicts survival in patients with cervical cancer. Int J Gynecol Cancer 20:1052–1057

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric D. Donnelly.

Ethics declarations

Compliance with ethical standards

This article does not contain any studies with human or animals subjects performed by any of the authors.

Funding sources

No funding support is associated with this study.

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gross, J.P., Strauss, J.B., Lurain, J. et al. Impact of obesity on treatment-related adverse events, disease recurrence, and survival in women with cervical carcinoma. J Radiat Oncol 5, 197–203 (2016). https://doi.org/10.1007/s13566-016-0243-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13566-016-0243-x

Keywords

Navigation